Blog
Why Laboratory Leaders Are Re‑Thinking Their LIS Strategy in 2026 - and Where LigoLab Fits
August 21, 2026
Editor’s Note: This post was originally published on January 9, 2026, and has been updated since.
Clinical and pathology laboratories in 2026 are under a convergence of pressures that few anticipated a decade ago. Test volumes remain high, reimbursement rules continue to tighten, digital pathology is becoming operationally mainstream, and staffing shortages show little sign of easing. At the same time, regulators and payers are demanding greater transparency, traceability, and financial accuracy from laboratory operations.
These forces are driving a renewed evaluation of one foundational question:
Is our laboratory information system helping us manage risk, or quietly amplifying it?
This is where advanced laboratory information systems such as the LigoLab Informatics Platform are increasingly part of the conversation.
Industry Insights: Best LIS Systems - Top Laboratory Information Systems Compared for Clinical, Pathology, and Outreach Labs
Industry Signals Driving Laboratory Information System Modernization
1. Reimbursement is Becoming Less Forgiving
Across the industry, labs are seeing expanded payer edits around medical necessity, diagnosis–procedure alignment, prior authorization, and eligibility verification. Post‑billing discovery of errors has become both costly and less recoverable.
What's changing in buyer behavior: Laboratories are prioritizing LIS systems that surface laboratory billing and coverage issues before testing begins, not weeks later through denials.
Case Study: In-House vs. Outsourced Laboratory Billing – Navigating the Best Path Forward for Your Lab
2. Digital Pathology is Crossing the Operational Threshold
Image management systems (IMS) and remote sign‑out are no longer pilot projects for many pathology groups. As digital pathology adoption grows, informatics platforms must manage digital and physical workflows together, or risk fragmenting case context.
What's changing in buyer behavior: Labs are looking beyond "digital compatibility" toward laboratory information system platforms that can natively support hybrid pathology models without parallel systems.
Case Study: OnePath - Transforming Pathology Lab Management Through Digital Innovation
3. Staffing Constraints Are Reshaping Workflow Design
Persistent shortages among technologists, histotechs, and laboratory billing specialists have shifted priorities. Manual checks, institutional memory, and heroics are no longer sustainable operating strategies.
What's changing in buyer behavior: Automation, rules‑based workflows, and real‑time visibility are now core evaluation criteria, not optional enhancements.
Get Insight: How Laboratory Information Systems Help Lab Operators Overcome Industry-Wide Staffing Shortages
4. Compliance Expectations Continue to Rise
Accreditation bodies increasingly expect defensible audit trails, controlled access to PHI, and end‑to‑end traceability across specimens, instruments, and users. Informal logs and external spreadsheets are becoming visible liabilities.
What's changing in buyer behavior: Labs are seeking LIS systems in which compliance is embedded in everyday work rather than maintained as a parallel process.
Discover More: Reducing Risk in the Modern Laboratory - A Comprehensive Approach
How LigoLab Aligns With These Industry Realities
A Unified Operational and Financial Data LIS Model
One of LigoLab's most differentiating characteristics is its native integration of operations and laboratory revenue cycle management (RCM). Clinical data, coding logic, payer rules, and laboratory billing workflows operate on a single foundation.
Why this resonates with prospects:
- Fewer missed or delayed charges.
- Earlier identification of non‑billable orders.
- Reduced denial rates.
- Less manual reconciliation between laboratory software systems.
As reimbursement pressure intensifies, this alignment directly addresses a growing source of financial risk.
Get Insight: The LigoLab Difference - Demonstrating the Power of Lab RCM Automation in the Clinical Laboratory
Workflow Intelligence That Reduces Human Dependency
LigoLab embeds configurable validation and routing rules at critical control points, including order entry, accessioning, testing, and sign-out.
Operational impact:
- Incomplete or incompatible orders are stopped early.
- Reflex testing and add‑ons occur consistently.
- Turnaround times become more predictable.
For labs navigating staffing volatility, this reduces reliance on individual vigilance and institutional memory.
Discover More: Unleashing Laboratory Excellence - Here’s How LigoLab’s Automation Engine Supercharges Lab Performance
Audit Readiness as a Daily Byproduct
Every action taken on a case viewing, editing, approving, or releasing is automatically logged. Quality control activities, instrument records, and user access are tracked within the same platform.
Strategic benefit: Audit preparation becomes incremental and continuous, rather than disruptive and episodic.
Discover More: A Detailed Look at How Modern Laboratory Information Systems Fully Support Quality Control
Scalability for Growth, Consolidation, and Specialization
Industry consolidation and service expansion remain active trends. Laboratory information systems that were sufficient for single‑site operations often struggle as complexity increases.
LigoLab's configurable architecture empowers laboratories to:
- Standardize workflows across locations.
- Add new test types without re‑architecting systems.
- Maintain operational visibility as volume grows.
This scalability is increasingly relevant as labs plan beyond short‑term fixes.
Digital Pathology Without Data Fragmentation
As the benefits of digital pathology accelerate adoption, maintaining case context becomes critical. LigoLab maintains images, annotations, and diagnostic data in connection with the same case record.
Why this matters: It reduces the risk of parallel workflows, orphaned digital assets, and context loss during review and sign‑out.
Industry Insights: ECPC’s Strategic Leap into Digital Pathology - A Connected Vision for the Future
Why This Message Resonates With Today's Buyers
Prospective customers evaluating the best laboratory information system software platforms are increasingly focused on resilience rather than features. Common evaluation questions include:
- Will this LIS system mitigate operational and financial risk as volume grows?
- Can it support digital and hybrid diagnostic models without added complexity?
- Does it simplify compliance rather than add overhead?
- Will it consolidate our technology stack (rather than expand it)?
LigoLab's emphasis on integration, automation, and transparency aligns directly with these concerns.
White Paper: Vendor to Partner - How Aligning with Your LIS Provider Can Transform Your Lab
Relevant Themes Driving Discovery
Search behavior among laboratory decision‑makers reflects these priorities. High‑intent themes include:
- Integrated LIS and laboratory revenue cycle management.
- Laboratory workflow automation.
- Digital pathology‑ready LIS software platforms.
- Reducing lab billing denials in medical laboratories.
- Scalable LIS systems for pathology and reference labs.
LigoLab naturally aligns with these terms because its platform addresses the same pressures labs are actively researching.
The Laboratory Information System as a Risk Management Strategy
The laboratory industry is no longer experiencing incremental change. Economic pressure, workforce constraints, and technological advancement are forcing a deeper reassessment of core systems.
In this environment, an advanced LIS system serves as a critical component of a laboratory’s risk management strategy. By unifying clinical and financial workflows, embedding automation, and providing real-time visibility, LigoLab helps laboratories reduce risk and operate (confidently) within an increasingly complex diagnostic landscape.
For prospects seeking stability, scalability, and long‑term readiness, that value proposition is becoming increasingly difficult to overlook.
Meet the Author
Suren Avunjian is the Co-Founder and Chief Executive Officer of LigoLab, where he leads company strategy, operations, and sustained growth across the clinical laboratory market. Under his leadership, LigoLab delivers enterprise-grade laboratory information system (LIS) and embedded laboratory revenue cycle management (lab billing) software supporting anatomic pathology, clinical laboratory, molecular diagnostics, and direct-to-consumer lab testing, all on a single, highly configurable platform.
Avunjian is the driving force behind LigoLab’s vision to modernize laboratory operations through automation, interoperability, and real-time visibility, paired with a deep commitment to customer service.
Widely respected for his industry insight, he is frequently featured in leading laboratory publications and forums.
Ready to Rethink Your LIS Strategy?
See how a unified platform can help your lab operate with confidence in an increasingly complex diagnostic landscape.
Learn More: Contact a LigoLab Product Specialist to Learn More!
Frequently Asked Questions About LIS Strategy and Laboratory Information Systems in 2026
Why are laboratories re-evaluating their LIS strategy in 2026?
Labs are facing a convergence of pressures, including tighter reimbursement rules, mainstream adoption of digital pathology, persistent staffing shortages, and rising compliance expectations, all of which are prompting a deeper look at whether their current LIS manages risk or adds to it.
How is reimbursement scrutiny changing what labs look for in an LIS?
Organizations are prioritizing systems that surface billing and coverage issues before testing begins, rather than discovering errors weeks later through denials, since post-billing error discovery has become costlier and harder to recover from.
Why is digital pathology integration important when choosing a laboratory information system?
As image management systems and remote sign-out become standard practice, laboratories need informatics platforms that unify digital and physical pathology workflows, keeping case data and diagnostic context connected within a single environment.
How does a unified data model reduce risk?
By running operational data, coding logic, payer rules, and laboratory billing workflows on a single foundation, labs see fewer missed or delayed charges, earlier identification of non-billable orders, reduced denial rates, and less manual reconciliation between systems.
How does workflow automation help labs facing staffing shortages?
Configurable validation and routing rules at order entry, accessioning, testing, and sign-out reduce reliance on individual vigilance and institutional memory, helping labs maintain consistent, predictable turnaround times even amid staffing volatility.
How Does Laboratory Information System Software Support Audit Readiness?
When every case action viewing, editing, approving, or releasing is automatically logged alongside quality control and instrument records, audit preparation becomes incremental and continuous rather than a disruptive, episodic scramble.
What questions should labs ask when evaluating an LIS platform in 2026?
Key questions include whether the system mitigates operational and financial risk as volume grows, supports digital and hybrid diagnostic models without adding complexity, simplifies rather than adds to compliance overhead, and consolidates the technology stack rather than expanding it.
